Synexus, Acurian, and Optimal are now AES.

Synexus now represents our site network capabilities, the largest in the world and growing. It’s the same great sites, now part of AES solutions.

Acurian now represents our core patient enrollment services, available globally. These services are underscored by the most fully identified patient data available for trials.

Optimal now represents the services we offer in both vaccines and oncology, using the same great sites but enhanced and extended with AES firepower.

The strong legacy of these companies is now reflected in our full suite of AES services. Combined, these services address site selection and patient enrollment in ways that no other company can – resulting in the new standard of clinical trial productivity.